Shopping Cart
Remove All
Your shopping cart is currently empty
FABPs ligand 6 (MF6) is a selective inhibitor of FABP5 and FABP7 that reduces levels of oxidative stress in the mouse spinal cord as well as lipopolysaccharide-stimulated interleukin-1β and tumor necrosis factor α accumulation in primary astrocyte cultures.FABPs ligand 6 has a potent protective function in oligodendrocytes of EAE mice through FABP5 inhibition. mitochondria with a strong protective function.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $132 | In Stock | In Stock | |
| 5 mg | $328 | In Stock | In Stock | |
| 10 mg | $562 | - | In Stock | |
| 25 mg | $1,090 | - | In Stock |
| Description | FABPs ligand 6 (MF6) is a selective inhibitor of FABP5 and FABP7 that reduces levels of oxidative stress in the mouse spinal cord as well as lipopolysaccharide-stimulated interleukin-1β and tumor necrosis factor α accumulation in primary astrocyte cultures.FABPs ligand 6 has a potent protective function in oligodendrocytes of EAE mice through FABP5 inhibition. mitochondria with a strong protective function. |
| Targets&IC50 | FABP7:20 nM (Kd), FABP5:874 nM (Kd) |
| In vitro | FABP ligand 6 has exhibited a high binding affinity for FABP5 (KD=874 nM) and FABP7 (KD=20 nM), but not for FABP3 (KD=1038 nM). [1] FABPs ligand 6 almost completely suppressed the upregulated oxidative stress levels and significantly decreased the number of 4-HNE-positive cells. [1] FABPs ligand 6-treated astrocytes, significantly attenuated IL-1b and TNF-a levels, indicating a suppressed inflammatory response. [1] |
| In vivo | EAE mice were orally administered FABPs ligand 6 (1 mg/kg), which is the maximum effective dose in brain ischemia 1 week before MOG immunisation of the EAE model. FABPs ligand 6 administration significantly reduced the severity of EAE. [1] |
| Synonyms | MF6 |
| Molecular Weight | 458.52 |
| Formula | C28H27FN2O3 |
| Cas No. | 2988135-14-2 |
| Smiles | O=C(O)CCCOC=1C=CC(F)=CC1C2=NN(C3=CC=C(C=C3)C(C)C)C(=C2)C=4C=CC=CC4 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL(218.09 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.36 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.